Could a week of breathing support before lung surgery cut risks in half?
NCT ID NCT01685580
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using a non-invasive ventilation machine for at least 7 days before lung cancer surgery could reduce lung and heart complications. The trial included 300 patients with lung cancer who also had breathing problems, obesity, or heart failure. The goal was to see if this approach could halve the rate of serious postoperative issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- non-invasive ventilation device (VPAP ST)
- What this could lead to
- If it works, this could make lung cancer surgery safer for patients with breathing or heart problems by reducing serious complications.
- What could go wrong
- This is a completed trial, but results may not apply to all patients. The technique is not a treatment for cancer itself, only a way to lower surgical risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHI Créteil
Créteil, 94010, France
-
CHRU de Brest - Hôpital Morvan
Brest, 29609, France
-
CHU Angers
Angers, 49933, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Saint-Etienne
Saint-Etienne, 42055, France
-
CHU de Rouen
Rouen, France, 76031, France
-
Centre Hospitalier Victor Dupouy
Argenteuil, France, 95100, France
-
Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France, 13616, France
-
Clinqiue du Grand Large
Brest, France, 29200, France
-
Hospital, Pasteur
Nice, 06000, France
-
Hôpital Nord Ouest Villefranche Sur Saône
Villefranche-sur-Saône, France, 69655, France
-
Hôpital Pontchaillou
Rennes, France, 35033, France
-
Inter Army Hospital
Clamart, 92141, France
-
Inter Army Hospital, Clermont-Tonnerre
Brest, 29609, France
-
Inter Army Hospital, Saint-Anne
Toulon, 83041, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?